Several cancers have been shown to exhibit deficiencies in DNA double-strand break (DSB) repair that makes them particularly sensitive to inhibitors of poly (ADP-ribose) polymerase 1 (PARP1), a key component of single strand break repair in human cells32, 33. This evidence concerns the gene PARP1 and cancer.